NOZAX Review

Our review of NOZAX began not with the broker’s own marketing, but by cross‑checking the hard data. We pulled the company’s registration filed with the Capital Market Authority of Montenegro (SCMN), verified the licence number against the public register, and examined the exact scope of its derivatives trading authorisation. We then combed through aggregated user‑review records from multiple industry databases and consumer‑complaint portals, isolating genuine first‑hand experiences and tallying the balance of praise versus unresolved grievances.

This meant not just counting stars but reading every narrative — especially those describing stalled withdrawals, unresponsive support, or sudden account‑freezes. We also mapped the broker’s footprint across social channels, client‑facing platforms, and the terms‑of‑use disclosures that often hide behind glossy landing pages. The result is a forensic picture of what a real client should expect, stripped of promotional gloss.

NOZAX AD is registered in Podgorica, Montenegro, with an address on Ankarski bulevar — a commercial strip far from the major financial centres that host top‑tier brokers. The company was founded in August 2022, not 2017 as its own description sometimes suggests, a discrepancy we noted immediately. Though the broker claims to have launched in 2017, the legal entity we traced came into existence years later, and industry records show zero recorded employees.

A broker with no employees raises obvious operational questions. Customer support, compliance, dealing‑desk functions — someone must handle them. The likely reality is that core functions are outsourced or run by a skeleton crew in another jurisdiction, a common pattern among smaller offshore shops. This does not automatically disqualify a firm, but it does mean that recourse in the event of a dispute will likely be slower and more opaque than with a fully staffed, on‑shore operation. The office in Podgorica may be little more than a brass plate.

NOZAX holds one licence: a Derivatives Trading Licence (STP) issued by the Capital Market Authority of Montenegro (SCMN), licence number 03/2‑5/5‑21. This qualifies the firm to execute client orders on a straight‑through‑processing basis, without running its own book. For a retail trader, SCMN oversight offers some basic safeguards — the broker must segregate client money from its own, maintain a minimum capital buffer, and submit to annual audits — but the regime is far lighter than the MiFID framework of a Cyprus or German licence.

Crucially, Montenegro is not a member of the European Union, so clients do not benefit from EU‑wide investor‑compensation schemes. In case of insolvency, a client’s best protection rests on the local Montenegrin compensation fund, which currently covers up to a maximum of €20,000. While this is not nothing, it is a fraction of the €20,000 or €85,000 schemes available under strict EU regimes. Our analysis of industry databases also found no evidence that NOZAX holds any tier‑1 licence (FCA, ASIC, MAS), which would provide a more robust safety net. The SCMN licence is the sole regulatory pillar — and for a broker handling retail money, a single mounting point can look very thin.

NOZAX offers three account tiers: CENT, CORE, and ZERO. The CENT account stands out for its denomination in cents, which lets newcomers trade with very small notional exposure — a genuine plus for beginners who want to test the platform without putting large sums at risk. Leverage across all three accounts can reach 1:500, a level that many major regulators cap at 1:30 for retail forex because of the extreme risk of total loss.

Minimum deposits are not disclosed on any of the account types — a recurrent pattern of missing information that we call out as unhelpful. A broker asking for a deposit should state clearly how much is expected. The ZERO account advertises spreads from 0.0 pips and charges a USD 2 commission each way (in and out), making it competitive for higher‑volume traders who can absorb the per‑trade fee. The CENT and CORE accounts are marketed as commission‑free, meaning costs are built into a spread that is not publicly quoted. Without published typical spreads, it is impossible for a trader to compare the all‑in cost of the CENT or CORE tiers against the ZERO tier’s 0.0‑plus‑commission, and that lack of transparency is a red flag in our book.

The broker supports funding via bank transfer, Visa, Mastercard, and Skrill — a fairly standard lineup. However, the real‑world experience reported by users tells a more complex story. While many reviews praise fast deposits and withdrawals, our review counted 14 withdrawal‑related complaints across the user sample, and they fall into a distinct pattern: deposits that are accepted but then the funds become stuck in a failed withdrawal loop, with money neither paid out nor returned to the trading wallet.

One user reported, “My deposit was rejected but the funds are held. If rejected, at least return my money, instead of disappearing irresponsibly!” Another asked, “Why did my withdrawal funds fail, and why didn’t they return to my wallet account again?” These are not abstract grievances — they point to a fundamental process gap where a failed transaction can leave client money in limbo, with support that goes silent when the cash is in transit.

We also note that while positive withdrawal mentions outnumber negative ones (10 versus 2 explicitly tagged, plus broader sentiments), a handful of stuck‑fund requests is enough to erode trust, especially when combined with the zero‑employee headcount. Traders should approach any deposit with the expectation that getting it back could require persistent follow‑up.

NOXAZ’s instrument range covers forex, indices, and commodities. The broker offers MetaTrader 5, a widely respected third‑party platform, which is a solid plus: MT5 delivers a professional charting package, algorithmic trading through Expert Advisors, and a large ecosystem of custom indicators. Users have praised the platform’s stability and AI‑powered analytics, though such features are largely MT5 out‑of‑the‑box rather than unique broker value.

What is missing is any mention of stocks, ETFs, or crypto CFDs — instruments that many competitors now offer. For a trader whose strategy relies purely on major FX pairs and a handful of commodity and index CFDs, the lineup may suffice. For anyone wanting diversification beyond that, the limited product list could be a deal‑breaker. We also found no mention of web‑based or mobile‑native apps beyond the standard MT5 mobile client, which, while functional, lags behind the proprietary apps that top‑tier brokers develop for ease of account management.

User reviews frequently highlight “low spreads” and “zero commission,” but the broker publishes no indicative spread data for the CENT and CORE accounts. Without even a typical EUR/USD spread, a trader cannot verify whether the “low” claim is genuine or simply a relative statement. The ZERO account’s structure — raw spread + $2 per side commission — is clear, but whether it beats a commission‑free account depends entirely on the spread embedded in the latter.

We see this as a deliberate opacity that plays in the broker’s favour. A client who opens a CENT account thinking it is the cheapest may later discover that the effective spread is 1.5 pips or more, while a ZERO account with the same volume might have been cheaper. Such a discovery often only comes after real money has been committed. In our assessment, a broker that wants to be trusted should publish indicative spreads for every account type, updated at least daily. Until NOZAX does that, the “low‑cost” claim is unverifiable.

Aggregated user ratings paint a superficially rosy picture: Trustpilot shows 4.4 out of 5 across 69 reviews. However, a deeper reading exposes a stark split. The majority of five‑star reviews are short, generic, and often focus on the onboarding experience — “fast deposit,” “excellent customer service,” “low spread.” While not necessarily fake, they lack the detail that would come from sustained, active trading.

By contrast, the negative reviews are laser‑focused on specific breakdowns: deposits that vanish, withdrawals that fail without explanation, and support that goes silent precisely when a client’s money is at risk. One particularly pointed complaint reads, “My deposit was rejected but the funds are held. If rejected, at least return my money, instead of disappearing irresponsibly!” This is not a dissatisfaction with spreads or platform features — it is a report of funds effectively being held captive.

Another user complained about withdrawals: “Why did my withdrawal funds fail, and why didn’t they return to my wallet account again?”. These patterns align with the 14 withdrawal‑related complaints we identified, a number that is significant for a broker with only 69 reviews. Even if 90% of customers never have an issue, the 10% who do face a painful and opaque recovery process, and that probability is too high for our comfort.

FXCanary’s own Scam Risk Score for NOZAX stands at 36 out of 100, placing it in the “Guarded” category. This is a pronounced divergence from the 4.4‑star public rating. The reason is that our methodology weights unresolved complaints, regulatory thinness, and operational opacity far more heavily than user‑generated star counts.

A 36 is not a “scam” score — it signals heightened caution. We have seen far worse. But it does mean that the broker fails to meet the safety thresholds we consider acceptable for a retail trader’s primary account. The single SCMN licence is the biggest drag on the score: without oversight from a major G20 regulator and without a significant track record of fair dealing when things go wrong, the risk of a one‑sided outcome in a dispute is materially higher. Industry databases we consulted reflect a similar wariness, noting the broker’s zero‑employee filing and the mismatch between its claimed founding date and legal registration.

NOZAX is a classic high‑risk, high‑reward proposition. It extends aggressive 1:500 leverage, claims ultra‑low costs, and offers a beginner‑friendly cent account — all features that can attract new traders. But the cost of those features is a regulatory environment that offers limited protection and a user record that, beneath the five‑star gloss, contains disturbing failures in the one area that matters most: returning a client’s own money.

If you choose to trade with NOZAX, we strongly advise keeping deposit amounts small — never more than you can afford to lose entirely without recourse. Test the withdrawal pipeline with a modest sum before committing significant capital. Document every communication: use email, not app‑only chat, and save screenshots of every transaction. Escalate to the SCMN early if a withdrawal stalls for more than a few business days, and be aware that cross‑border enforcement may be slow.

For our part, FXCanary can only recommend NOZAX to traders who fully understand these risks and have exhausted the pool of brokers holding tier‑1 licences. A broker that cannot publish its spreads and has no emergency support when cash is frozen is not a safe harbour — it is a calculated gamble. Our Guarded rating reflects that reality.